Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 18 de 18
1.
Arch Physiol Biochem ; 128(1): 223-230, 2022 Feb.
Article En | MEDLINE | ID: mdl-31595805

The aim of this study was to investigate the ability of tannic acid (TA) in preventing memory deficits and neurochemical alterations observed in a model for Sporadic Dementia of Alzheimer's Type. Rats were treated with TA (30 mg/kg) daily for 21 days, and subsequently received intracerebroventricular injection of streptozotocin (STZ). We observed that STZ induced learning and memory impairments; however, treatment with TA was able to prevent these effects. In cerebral cortex and hippocampus, STZ induced an increase in acetylcholinesterase activity, reduced Na+, K+-ATPase activity and induced oxidative stress increasing thiobarbituric acid-reactive substances, nitrites and reactive oxygen species levels and reducing the activity of antioxidant enzymes. Treatment with TA was able in prevent the major of these neurochemical alterations. In conclusion, TA prevented memory deficits, alterations in brain enzyme activities, and oxidative damage induced by STZ. Thus, TA can be an interesting strategy in the prevention of Sporadic Alzheimer's Disease.


Alzheimer Disease , Acetylcholinesterase/metabolism , Adenosine Triphosphatases , Alzheimer Disease/chemically induced , Alzheimer Disease/drug therapy , Alzheimer Disease/prevention & control , Animals , Disease Models, Animal , Maze Learning , Oxidation-Reduction , Oxidative Stress , Rats , Rats, Wistar , Streptozocin/toxicity , Tannins
2.
Life Sci ; 277: 119421, 2021 Jul 15.
Article En | MEDLINE | ID: mdl-33785337

Diabetes mellitus (DM) is a metabolic disorder characterized by a chronic hyperglycemia state, increased oxidative stress parameters, and inflammatory processes. AIMS: To evaluate the effect of caffeic acid (CA) on ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) and adenosine deaminase (ADA) enzymatic activity and expression of the A2A receptor of the purinergic system, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymatic activity and expression of the α7nAChR receptor of the cholinergic system as well as inflammatory and oxidative parameters in diabetic rats. METHODS: Diabetes was induced by a single dose intraperitoneally of streptozotocin (STZ, 55 mg/kg). Animals were divided into six groups (n = 10): control/oil; control/CA 10 mg/kg; control/CA 50 mg/kg; diabetic/oil; diabetic/CA 10 mg/kg; and diabetic/CA 50 mg/kg treated for thirty days by gavage. RESULTS: CA treatment reduced ATP and ADP hydrolysis (lymphocytes) and ATP levels (serum), and reversed the increase in ADA and AChE (lymphocytes), BuChE (serum), and myeloperoxidase (MPO, plasma) activities in diabetic rats. CA treatment did not attenuate the increase in IL-1ß and IL-6 gene expression (lymphocytes) in the diabetic state; however, it increased IL-10 and A2A gene expression, regardless of the animals' condition (healthy or diabetic), and α7nAChR gene expression. Additionally, CA attenuated the increase in oxidative stress markers and reversed the decrease in antioxidant parameters of diabetic animals. CONCLUSION: Overall, our findings indicated that CA treatment positively modulated purinergic and cholinergic enzyme activities and receptor expression, and improved oxi-inflammatory parameters, thus suggesting that this phenolic acid could improve redox homeostasis dysregulation and purinergic and cholinergic signaling in the diabetic state.


Acetylcholinesterase/metabolism , Butyrylcholinesterase/metabolism , Caffeic Acids/pharmacology , Diabetes Mellitus, Experimental/pathology , Gene Expression Regulation/drug effects , Inflammation Mediators/metabolism , Oxidative Stress/drug effects , Acetylcholinesterase/genetics , Adenosine Deaminase/genetics , Adenosine Deaminase/metabolism , Animals , Antigens, CD/genetics , Antigens, CD/metabolism , Antioxidants/pharmacology , Apyrase/genetics , Apyrase/metabolism , Butyrylcholinesterase/genetics , Cytokines/metabolism , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/pathology , GPI-Linked Proteins/genetics , GPI-Linked Proteins/metabolism , Lipid Peroxidation/drug effects , Lymphocytes/drug effects , Lymphocytes/metabolism , Lymphocytes/pathology , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Peroxidase/metabolism , Rats , Rats, Wistar , alpha7 Nicotinic Acetylcholine Receptor/genetics , alpha7 Nicotinic Acetylcholine Receptor/metabolism
3.
Redox Rep ; 24(1): 34-40, 2019 Dec.
Article En | MEDLINE | ID: mdl-31100998

OBJECTIVE: Investigate Vitamin D3 (VD3) effect on the Acetylcholinesterase (AChE), oxidative damage and behavioral tests in animals subjected to Intracerebroventicular injection of Streptozotocin (ICV-STZ) simulating a Sporadic Dementia of Alzheimer's Type (SDAT) and treated with VD3 (21 days). METHODS: Animals were divided into eight groups: Vehicle, VD12.5 µg/kg, VD42 µg/kg, VD125 µg/kg, STZ, STZ+VD12.5 µg/kg, STZ+VD42 µg/kg, STZ+VD125 µg/kg. RESULTS: VD3 prevented the increase in AChE in groups of VD42 µg/kg and VD125 µg/kg; in AChE of synaptossomes and TBARS levels prevented the increase in group VD125 µg/kg; in ROS levels there was not a significant difference; for the Carbonyl Content all doses prevented the increase. Total Thiols prevent the decrease in VD42 µg/kg and VD125 µg/kg, and Reduced Glutathione prevented the decrease in VD125 µg/kg, Oxidized Glutathione prevented the increase in VD125 µg/kg. In relation to behavioral tests, the VD3 prevented the increase in time to find (days 2 and 3), in the time to find the platform (day 3) and in time spent in the quadrant (day 2). However, in relation to crossings there was not difference in groups. These results indicated the therapeutic effect of the VD3 in model of STZ in rats.


Acetylcholinesterase/metabolism , Alzheimer Disease/metabolism , Antioxidants/metabolism , Cholecalciferol/therapeutic use , Animals , Ascorbic Acid/metabolism , Dementia/metabolism , Disease Models, Animal , Lipid Peroxidation/drug effects , Male , Memory/drug effects , Oxidative Stress/drug effects , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
4.
J Cell Biochem ; 120(3): 3232-3242, 2019 03.
Article En | MEDLINE | ID: mdl-30230598

Sepsis is a generalized infection that involves alterations in inflammatory parameters, oxidant status, and purinergic signaling in many tissues. Physical exercise has emerged as a tool to prevent this disease because of its anti-inflammatory and antioxidant properties. Thus, in this study, we investigated the effects of physical exercise on preventing alterations in purinergic system components, oxidative stress, and inflammatory parameters in lipopolysaccharide (LPS)-induced sepsis in rats. Male Wistar rats were divided into four groups: control, exercise (EX), LPS, and EX+LPS. The resisted physical exercise was performed for 12 weeks on a ladder with 1 m height. After 72 hours of the last exercise session, the animals received 2.5 mg/kg of LPS for induction of sepsis, and after 24 hours, lungs and blood samples were collected for analysis. The results showed that the exercise protocol used was able to prevent, in septic animals: (1) the increase in body temperature; (2) the increase of lipid peroxidation and reactive species levels in the lung, (3) the increase in adenosine triphosphate levels in serum; (4) the change in the activity of the enzymes ectonucleotidases in lymphocytes, partially; (5) the change in the density of purinergic enzymes and receptors in the lung, and (6) the increase of IL-6 and IL-1ß gene expression. Our results revealed the involvement of purinergic signaling and oxidative damage in the mechanisms by which exercise prevents sepsis aggravations. Therefore, the regular practice of physical exercise is encouraged as a better way to prepare the body against sepsis complications.


Lipopolysaccharides/toxicity , Physical Conditioning, Animal/physiology , Sepsis/chemically induced , Sepsis/prevention & control , Animals , Antioxidants/metabolism , Catalase/metabolism , Lipid Peroxidation/drug effects , Lung/drug effects , Lung/metabolism , Male , Oxidation-Reduction/drug effects , Oxidative Stress/drug effects , Rats , Rats, Wistar , Sepsis/metabolism , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/metabolism
5.
Food Res Int ; 109: 358-367, 2018 07.
Article En | MEDLINE | ID: mdl-29803461

Tiger nut tubers have been reportedly used for the treatment of erectile dysfunction (ED) in folk medicine without scientific basis. Hence, this study evaluated the effect of tiger nut on erectile dysfunction by assessing biochemical parameters relevant to ED in male rats by nitric oxide synthase (NOS) inhibitor, Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME) treatment. Rats were divided into five groups (n = 10) each: Control group; l-NAME plus basal diet; l-NAME plus Sildenafil citrate; diet supplemented processed tiger nut (20%) plus l-NAME;diet supplemented raw tiger nut (20%) plus l-NAME. l-NAME pre-treatment (40 mg/kg/day) lasted for 14 days. Arginase, acetycholinesterase (AChE) and adenosine deaminase (ADA) activities as well as nitric oxide levels (NO) in serum, brain and penile tissue were measured. l-NAME increased the activity of arginase, AChE and ADA and reduced NO levels. However, dietary supplementation with tiger nut caused a reduction on the activities of the above enzymes and up regulated nitric oxide levels when compared to the control group. The effect of tiger nut supplemented diet may be said to prevent alterations of the activities of the enzymes relevant in erectile function. Quercetin was revealed to be the most active component of tiger nut tuber by HPLC finger printing.


Animal Feed , Cyperus/chemistry , Dietary Supplements , Erectile Dysfunction/prevention & control , NG-Nitroarginine Methyl Ester , Penile Erection/drug effects , Penis/drug effects , Plant Extracts/pharmacology , Quercetin/pharmacology , Acetylcholinesterase/blood , Adenosine Deaminase/blood , Animals , Arginase/blood , Brain/drug effects , Brain/metabolism , Disease Models, Animal , Erectile Dysfunction/chemically induced , Erectile Dysfunction/metabolism , Erectile Dysfunction/physiopathology , GPI-Linked Proteins/blood , Male , Membrane Proteins/blood , Nitric Oxide/blood , Penis/metabolism , Penis/physiopathology , Plant Extracts/isolation & purification , Plant Tubers/chemistry , Quercetin/isolation & purification , Rats, Wistar
6.
J Cell Biochem ; 119(7): 6249-6257, 2018 07.
Article En | MEDLINE | ID: mdl-29663535

The purinergic system has an important role in the regulation of vascular functions. The interference of thyroid hormones in this system and in cardiovascular events has been studied in recent years. However, the mechanisms involved in vascular, purinergic, and oxidative changes in thyroid disorders are not completely understood. Therefore, the present study aimed to assess purinergic enzyme activity in platelets from rats with hypothyroidism and hyperthyroidism induced, respectively, by continuous exposure to methimazole (MMI) at 20 mg/100 mL or L-thyroxine at 1.2 mg/100 mL in drinking water for 1 month. Results showed that rats exposed to L-thyroxine had a significant decrease in NTPDase activity, wherein ATP hydrolysis was 53% lower and ADP hydrolysis was 40% lower. Moreover, ecto-5'-nucleotidase activity was decreased in both groups, by 39% in the hypothyroidism group and by 52% in the hyperthyroidism group. On the other hand, adenosine deaminase (ADA) activity was increased in hyperthyroidism (75%), and nucleotide pyrophosphatase/phosphodiesterase (NPP) activity was increased in animals with hypothyroidism (127%) and those with hyperthyroidism (128%). Our findings suggest that changes in purinergic enzyme and purine levels could contribute to the undesirable effects of thyroid disturbances. Moreover, oxidative stress and, in particular, a high level of ROS production, showed a causal relation with changes in ectonucleotidase activity and nucleotide and nucleoside levels.


5'-Nucleotidase/metabolism , Adenosine Deaminase/metabolism , Antigens, CD/metabolism , Apyrase/metabolism , Blood Platelets/enzymology , Hyperthyroidism/enzymology , Hypothyroidism/enzymology , Nucleotides/metabolism , Adenosine Triphosphate/metabolism , Animals , Hydrolysis , Hyperthyroidism/blood , Hyperthyroidism/chemically induced , Hypothyroidism/blood , Hypothyroidism/chemically induced , Male , Methimazole/toxicity , Oxidative Stress , Rats , Rats, Wistar
7.
Environ Toxicol ; 32(1): 70-83, 2017 Jan.
Article En | MEDLINE | ID: mdl-26592365

This study investigated the protective effect of curcumin on memory loss and on the alteration of acetylcholinesterase and ectonucleotidases activities in rats exposed chronically to cadmium (Cd). Rats received Cd (1 mg/kg) and curcumin (30, 60, or 90 mg/kg) by oral gavage 5 days a week for 3 months. The animals were divided into eight groups: vehicle (saline/oil), saline/curcumin 30 mg/kg, saline/curcumin 60 mg/kg, saline/curcumin 90 mg/kg, Cd/oil, Cd/curcumin 30 mg/kg, Cd/curcumin 60 mg/kg, and Cd/curcumin 90 mg/kg. Curcumin prevented the decrease in the step-down latency induced by Cd. In cerebral cortex synaptosomes, Cd-exposed rats showed an increase in acetylcholinesterase and NTPDase (ATP and ADP as substrates) activities and a decrease in the 5'-nucleotidase activity. Curcumin was not able to prevent the effect of Cd on acetylcholinesterase activity, but it prevented the effects caused by Cd on NTPDase (ATP and ADP as substrate) and 5'-nucleotidase activities. Increased acetylcholinesterase activity was observed in different brain structures, whole blood and lymphocytes of the Cd-treated group. In addition, Cd increased lipid peroxidation in different brain structures. Higher doses of curcumin were more effective in preventing these effects. These findings show that curcumin prevented the Cd-mediated memory impairment, demonstrating that this compound has a neuroprotective role and is capable of modulating acetylcholinesterase, NTPDase, and 5'-nucleotidase activities. Finally, it highlights the possibility of using curcumin as an adjuvant against toxicological conditions involving Cd exposure. © 2015 Wiley Periodicals, Inc. Environ Toxicol 32: 70-83, 2017.


Cadmium Poisoning/physiopathology , Curcumin/therapeutic use , Memory Disorders/chemically induced , Memory Disorders/prevention & control , Parasympathetic Nervous System/drug effects , Receptors, Purinergic/drug effects , Signal Transduction/drug effects , Animals , Avoidance Learning/drug effects , Cadmium Poisoning/enzymology , Curcumin/administration & dosage , Dose-Response Relationship, Drug , Electroshock , Lipid Peroxidation/drug effects , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Synaptosomes/drug effects , Synaptosomes/enzymology
8.
Biomarkers ; 21(6): 530-7, 2016 Sep.
Article En | MEDLINE | ID: mdl-27075266

CONTEXT: This study aims to explore the potential of new inflammatory markers for improving the challenging diagnosis of acute appendicitis (AA). METHODS: Levels of IL-1, IL-6, IL-8, IL-10, CRP, INF-γ, and TNF-α in serum were measured in 73 patients with AA. Oxidative stress and antioxidant enzymes were analyzed. RESULTS: Serum levels of interleukins, TNF-α, and INF-γ were significantly elevated in patients with appendicitis (p < 0.0001), except for IL-10, which presented decreased levels. There were no significant differences in SOD (p = 0.29), CAT (p = 0.19), or TBARS levels (p = 0.18), whereas protein carbonyls presented significant increase (p < 0.0001). CONCLUSION: Evaluating these biomarkers could aid in diagnosing AA.


Appendicitis/blood , Cytokines/blood , Oxidative Stress , Adolescent , Adult , Aged , Appendicitis/diagnosis , Biomarkers/blood , Case-Control Studies , Catalase/blood , Female , Humans , Male , Middle Aged , Superoxide Dismutase/blood , Young Adult
9.
J Physiol Biochem ; 71(4): 743-51, 2015 Dec.
Article En | MEDLINE | ID: mdl-26452500

In the present study, we investigated the efficiency of rosmarinic acid (RA) in preventing the alteration of oxidative parameters in the liver and kidney of diabetic rats induced by streptozotocin (STZ). The animals were divided into six groups (n = 8): control, ethanol, RA 10 mg/kg, diabetic, diabetic/ethanol, and diabetic/RA 10 mg/kg. After 3 weeks of treatment, we found that TBARS levels in liver and kidney were significantly increased in the diabetic/saline group and the administration of RA prevented this increase in the liver and kidney (P < 0.05). Diabetes caused a significant decrease in the activity of superoxide dismutase (SOD) and catalase (CAT) in the diabetes/saline group (P < 0.05). However, the treatment with 10 mg/kg RA (antioxidant) prevented this alteration in SOD and CAT activity in the diabetic RA group (P < 0.05). In addition, RA reverses the decrease in ascorbic acid and non-protein-thiol (NPSH) levels in diabetic rats. The treatment with RA also prevented the decrease in the Delta-aminolevulinic acid dehydratase (ALA-D) activity in the liver and kidney of diabetic rats. Furthermore, RA did not have any effect on glycemic levels. These results indicate that RA effectively reduced the oxidative stress induced by STZ, suggesting that RA is a potential candidate for the prevention and treatment of pathological conditions in diabetic models.


Antioxidants/pharmacology , Cinnamates/pharmacology , Depsides/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Kidney/metabolism , Liver/metabolism , Animals , Antioxidants/therapeutic use , Ascorbic Acid/metabolism , Biomarkers/metabolism , Blood Glucose , Cinnamates/therapeutic use , Depsides/therapeutic use , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/metabolism , Drug Evaluation, Preclinical , Kidney/drug effects , Liver/drug effects , Male , Malondialdehyde/metabolism , Oxidative Stress , Rats, Wistar , Streptozocin , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Rosmarinic Acid
10.
Mol Cell Biochem ; 405(1-2): 11-21, 2015 Jul.
Article En | MEDLINE | ID: mdl-25893731

This study was designed to assess the potential effect of vitamin D3 (VD3) in avoiding atherothrombosis by modulation of lipid metabolism and platelet activation in type 1 diabetic rats. Male wistar rats were divided into eight groups (n = 5-10): Control/Saline (Sal); Control/Metformin 500 mg/kg (Metf); Control/Vitamin D3 90 µg/kg (VD3); Control/Metformin 500 mg/kg + VD3 90 µg/kg (Metf + VD3); Diabetic/Saline (Sal); Diabetic/Metformin 500 mg/kg (Metf); Diabetic/Vitamin D3 90 µg/kg (VD3); Diabetic/Metformin 500 mg/kg + VD3 90 µg/kg (Metf + VD3). Treatments were administered during 30 days after diabetes induction with streptozotocin (STZ). After 31 days, the rats were euthanized and blood was collected and separated into serum and platelets, both used for lipid profile and ectonucleotidase activity assays, respectively. Ectonucleoside triphosphate phosphohydrolase (E-NTPDase), ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP), and 5'-nucleotidase and adenosine deaminase (E-ADA) were significantly higher in the Diabetic than in Control group. Treatment with Metf and/or VD3 prevented the increase in NTPDase and E-NPP activities in diabetic rats. Only Metf + VD3 significantly prevented the increase in 5'-nucleotidase. VD3 alone, but not Metf, prevented the increase in ADA activity when compared to saline-treated diabetic rats. Treatment of rats with VD3, Metf, and Metf + VD3 was also effective in the prevention of lipid metabolism disorder in diabetic and was able to ameliorate lipid metabolism in non-diabetic rats. These results provide evidence for the potential of Metf and VD3 in the treatment of platelet dysfunction and lipid metabolism impairment in T1D, which may be important in the control and prevention of atherothrombosis in diabetes.


5'-Nucleotidase/metabolism , Cholecalciferol/pharmacology , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/metabolism , Lipids/blood , Adenosine Deaminase/metabolism , Adenosine Triphosphatases/metabolism , Animals , Blood Platelets/drug effects , Blood Platelets/metabolism , Lipid Metabolism/drug effects , Male , Metformin/pharmacology , Phosphoric Diester Hydrolases/metabolism , Pyrophosphatases/metabolism , Rats , Rats, Wistar , Streptozocin/pharmacology
11.
Mol Cell Biochem ; 396(1-2): 201-11, 2014 Nov.
Article En | MEDLINE | ID: mdl-25064450

The ex vivo and in vitro effects of quercetin on NTPDase, adenosine deaminase (ADA), and acetycholinesterase (AChE) activities in lymphocytes, as well as the effects of quercetin on butyrylcholinesterase (BChE) activity in serum and myeloperoxidase (MPO) activity in plasma were determined in rats. For the ex vivo experiment, animals were orally exposed to Cadmium (Cd) for 45 days. Animals were divided into eight groups: saline/ethanol, saline/Querc 5 mg/kg, saline/Querc 25 mg/kg, saline/Querc 50 mg/kg, Cd/ethanol, Cd/Querc 5 mg/kg, Cd/Querc 25 mg/kg, and Cd/Querc 50 mg/kg. The ex vivo data showed an increase in the ATP and ADP hydrolysis and ADA activity in Cd-exposed rats when compared to the control group. The treatment with quercetin 25 and 50 mg/kg prevented this increase in the ATP and ADP hydrolysis, while the treatment with quercetin 5, 25, and 50 mg/kg prevented the increase in the ADA activity. AChE, BChE, and MPO activities ex vivo presented an increase in the Cd-exposed group when compared to the control group, and the treatment with quercetin 5, 25, and 50 mg/kg prevented this increase caused by Cd exposure. The in vitro experiment showed that quercetin 5, 10, 25, or 50 µM decreased the ADA activity proportionally to the increase of the concentrations of quercetin when compared to the control group. Thus, we can suggest that the quercetin is able to modulate NTPDase, ADA, AChE, and MPO activities and contribute to maintain the levels of ATP, adenosine, and acetylcholine normal, respectively, exhibiting potent pro-inflammatory and anti-inflammatory actions.


Cadmium/toxicity , Cholinesterases/metabolism , Lymphocytes/drug effects , Peroxidase/metabolism , Quercetin/pharmacology , Acetylcholinesterase/metabolism , Adenosine Deaminase/metabolism , Animals , Butyrylcholinesterase/blood , Dose-Response Relationship, Drug , Hydrolysis , Lymphocytes/metabolism , Male , Protective Agents/pharmacology , Pyrophosphatases/metabolism , Rats, Wistar , Toxicity Tests/methods
12.
Cell Biochem Funct ; 32(6): 502-10, 2014 Aug.
Article En | MEDLINE | ID: mdl-24947461

Diabetes is associated with long-term complications in the brain and reduced cognitive ability. Vitamin D3 (VD3 ) appears to be involved in the amelioration of hyperglycaemia in streptozotocin (STZ)-induced diabetic rats. Our aim was to analyse the potential of VD3 in avoiding brain damage through evaluation of acetylcholinesterase (AChE), Na(+) K(+) -adenosine triphosphatase (ATPase) and delta aminolevulinate dehydratase (δ-ALA-D) activities and thiobarbituric acid reactive substance (TBARS) levels from cerebral cortex, as well as memory in STZ-induced diabetic rats. Animals were divided into eight groups (n = 5): control/saline, control/metformin (Metf), control/VD3 , control/Metf + VD3 , diabetic/saline, diabetic/Metf, diabetic/VD3 and diabetic/Metf + VD3 . Thirty days after treatment, animals were submitted to contextual fear-conditioning and open-field behavioural tests, after which they were sacrificed and the cerebral cortex was dissected. Our results demonstrate a significant memory deficit, an increase in AChE activity and TBARS levels and a decrease in δ-ALA-D and Na(+) K(+) -ATPase activities in diabetic rats when compared with the controls. Treatment of diabetic rats with Metf and VD3 prevented the increase in AChE activity when compared with the diabetic/saline group. In treated diabetic rats, the decrease in Na(+) K(+) -ATPase was reverted when compared with non-treated rats, but the increase in δ-ALA-D activity was not. VD3 prevented diabetes-induced TBARS level and improved memory. Our results show that VD3 can avoid cognitive deficit through prevention of changes in important enzymes such as Na(+) K(+) -ATPase and AChE in cerebral cortex in type 1 diabetic rats.


Cholecalciferol/pharmacology , Diabetes Mellitus, Type 1/drug therapy , Vitamins/pharmacology , Acetylcholinesterase/metabolism , Animals , Blood Glucose/drug effects , Body Weight/drug effects , Cerebral Cortex/drug effects , Cholecalciferol/therapeutic use , Diabetes Mellitus, Type 1/chemically induced , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/psychology , Eating/drug effects , Fear/drug effects , Hypoglycemic Agents/pharmacology , Male , Memory/drug effects , Metformin/pharmacology , Porphobilinogen Synthase/metabolism , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/metabolism , Streptozocin , Thiobarbituric Acid Reactive Substances/metabolism , Vitamins/therapeutic use
13.
Food Chem Toxicol ; 56: 459-66, 2013 Jun.
Article En | MEDLINE | ID: mdl-23454297

This study evaluated the effects of caffeic acid on ectonucleotidase activities such as NTPDase (nucleoside triphosphate diphosphohydrolase), Ecto-NPP (nucleotide pyrophosphatase/phosphodiesterase), 5'-nucleotidase and adenosine deaminase (ADA) in platelets and lymphocytes of rats, as well as in the profile of platelet aggregation. Animals were divided into five groups: I (control); II (oil); III (caffeic acid 10 mg/kg); IV (caffeic acid 50 mg/kg); and V (caffeic acid 100 mg/kg). Animals were treated with caffeic acid diluted in oil for 30 days. In platelets, caffeic acid decreased the ATP hydrolysis and increased ADP hydrolysis in groups III, IV and V when compared to control (P<0.05). The 5'-nucleotidase activity was decreased, while E-NPP and ADA activities were increased in platelets of rats of groups III, IV and V (P<0.05). Caffeic acid reduced significantly the platelet aggregation in the animals of groups III, IV and V in relation to group I (P<0.05). In lymphocytes, the NTPDase and ADA activities were increased in all groups treated with caffeic acid when compared to control (P<0.05). These findings demonstrated that the enzymes were altered in tissues by caffeic acid and this compound decreased the platelet aggregation suggesting that caffeic acid should be considered a potentially therapeutic agent in disorders related to the purinergic system.


Adenine Nucleotides/metabolism , Blood Platelets/drug effects , Caffeic Acids/pharmacology , Lymphocytes/drug effects , Adenosine Deaminase/metabolism , Adenosine Triphosphatases/metabolism , Animals , Blood Platelets/enzymology , Dose-Response Relationship, Drug , Hydrolysis , Lymphocytes/enzymology , Male , Phosphoric Diester Hydrolases/metabolism , Platelet Aggregation/drug effects , Pyrophosphatases/metabolism , Rats , Rats, Wistar
14.
Mol Cell Biochem ; 378(1-2): 247-55, 2013 Jun.
Article En | MEDLINE | ID: mdl-23516038

Perinatal hypoxic-ischemic (HI) brain injury is a common problem with severe neurologic sequelae. The definitive brain injury is a consequence of pathophysiological mechanisms that begin at the moment of HI insult and may extend for days or weeks. In this context, the inflammatory response and the formation of reactive oxygen species seem to play a key role during evolution of brain damage after injury. Thus, the aim of this study was to describe the chronological sequence of acetylcholinesterase (AChE) activity and the lipid peroxidation changes in the cerebral cortex using the classic model of neonatal HI. Furthermore, the erythrocyte AChE and adenosine deaminase (ADA) activities as well as the serum levels of proinflammatory cytokines were assessed. We observed that neonatal HI caused an increase of lipid peroxidation immediately after HI insult, which remained for several days afterward. There was a time-related change in the AChE activity in the cerebral cortex and the same was observed in erythrocyte AChE and ADA activities. In addition, immediately after HI, ADA activity showed a strong positive correlation with all proinflammatory cytokines assessed. Together, these findings may help the understanding of some mechanism related to the pathophysiology of neonatal HI, therefore highlighting the putative therapeutic targets to minimize brain injury and enhance recovery.


Acetylcholinesterase/metabolism , Adenosine Deaminase/metabolism , Brain Ischemia/enzymology , Cerebral Cortex/enzymology , Cytokines/blood , Erythrocytes/enzymology , Animals , Animals, Newborn , Brain Ischemia/blood , Cell Hypoxia , Cerebral Cortex/blood supply , Inflammation Mediators/metabolism , Lipid Peroxidation , Male , Rats , Rats, Wistar
15.
Mol Cell Biochem ; 374(1-2): 137-48, 2013 Feb.
Article En | MEDLINE | ID: mdl-23180243

We aimed to examine the nucleoside triphosphate diphosphohydrolases (NTPDase) in lymphocytes; adenosine deaminase (ADA) and butyrylcholinesterase (BChE) in serum; and acetylcholinesterase (AChE), superoxide dismutase (SOD), and catalase (CAT) activity in whole blood; since these enzymes are involved in inflammation responses as well as in oxidative stress conditions. We also checked the levels of total thiols (T-SH), non-protein thiols (NPSH), and thiobarbituric acid reactive substances (TBARS) in serum of patients with lung cancer. We collected blood samples from patients (n = 31) previously treated for lung cancer with chemotherapy. Patients were classified as stage IIIb and IV according to the Union for International Cancer Control (UICC). The results showed a significant increase in the hydrolysis of ATP, ADP, and adenosine in patients when compared with the control group. The activity of AChE, SOD, and CAT as well as the T-SH and NPSH levels were higher in patients group and TBARS levels were lower in patients compared with the control group. These findings demonstrated that the enzymes activity involved in the control of inflammatory and immune processes as well as the oxidative stress parameters are altered in patients with lung cancer.


Biomarkers, Tumor/blood , Cholinesterases/blood , Inflammation/enzymology , Lung Neoplasms/metabolism , Oxidative Stress , Acetylcholinesterase/blood , Adenosine Deaminase/blood , Aged , Antineoplastic Agents/therapeutic use , Butyrylcholinesterase/blood , Catalase/blood , Cholinesterases/metabolism , Cisplatin/therapeutic use , Deoxycytidine/analogs & derivatives , Deoxycytidine/therapeutic use , Female , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/enzymology , Lymphocytes/enzymology , Male , Middle Aged , Neoplasm Staging , Nucleoside-Triphosphatase/metabolism , Smoking/blood , Sulfhydryl Compounds/blood , Superoxide Dismutase/blood , Thiobarbituric Acid Reactive Substances/analysis , Gemcitabine
16.
Int J Dev Neurosci ; 31(1): 69-74, 2013 Feb.
Article En | MEDLINE | ID: mdl-23147562

The purpose of the present investigation was to evaluate the hydrolysis of adenine nucleotides on synaptosomes and platelets obtained from rats exposed to cadmium (Cd) and treated with N-acetylcysteine (NAC). Rats received Cd (2 mg/kg) and NAC (150 mg/kg) by gavage every other day for 30 days. Animals were divided into four groups (n = 4-6): control/saline, NAC, Cd, and Cd/NAC. The results of this study demonstrated that NTPDase and 5'-nucleotidase activities were increased in the cerebral cortex synaptosomes of Cd-poisoned rats, and NAC co-treatment reversed these activities to the control levels. In relation to hippocampus synaptosomes, no differences on the NTPDase and 5'-nucleotidase activities of Cd-poisoned rats were observed and only the 5'-nucleotidase activity was increased by the administration of NAC per se. In platelets, Cd-intoxicated rats showed a decreased NTPDase activity and no difference in the 5'-nucleotidase activity; NAC co-treatment was inefficient in counteracting this undesirable effect. Our findings reveal that adenine nucleotide hydrolysis in synaptosomes and platelets of rats were altered after Cd exposure leading to a compensatory response in the central nervous system and acting as a modulator of the platelet activity. NAC was able to modulate the purinergic system which is interesting since the regulation of these enzymes could have potential therapeutic importance. Thus, our results reinforce the importance of the study of the ecto-nucleotidases pathway in poisoning conditions and highlight the possibility of using antioxidants such as NAC as adjuvant against toxicological conditions.


5'-Nucleotidase/metabolism , Acetylcysteine/pharmacology , Blood Platelets/drug effects , Cadmium/pharmacology , Free Radical Scavengers/pharmacology , Pyrophosphatases/metabolism , Synaptosomes/drug effects , Analysis of Variance , Animals , Brain/ultrastructure , Male , Rats , Rats, Wistar
17.
Food Chem Toxicol ; 50(10): 3709-18, 2012 Oct.
Article En | MEDLINE | ID: mdl-22819775

This study investigated the cadmium (Cd) intoxication on cognitive, motor and anxiety performance of rats subjected to long-term exposure to diet with Cd salt or with Cd from contaminated potato tubers. Potato plantlets were micropropagated in MS medium and transplanted to plastic trays containing sand. Tubers were collected, planted in sand boxes and cultivated with 0 or 10 µM Cd and, after were oven-dried, powder processed and used for diet. Rats were divided into six groups and fed different diets for 5 months: control, potato, potato+Cd, 1, 5 or 25 mg/kg CdCl2. Cd exposure increased Cd concentration in brain regions. There was a significant decrease in the step-down latency in Cd-intoxicated rats and, elevated plus maze task revealed an anxiolytic effect in rats fed potato diet per se, and an anxiogenic effect in rats fed 25 mg/kg Cd. The brain structures of rats exposed to Cd salt or Cd from tubers showed an increased AChE activity, but Na+,K+-ATPase decreased in cortex, hypothalamus, and cerebellum. Therefore, we suggest an association between the long-term diet of potato tuber and a clear anxiolytic effect. Moreover, we observed an impaired cognition and enhanced anxiety-like behavior displayed by Cd-intoxicated rats coupled with a marked increase of brain Cd concentration, and increase and decrease of AChE and Na+,K+-ATPase activities, respectively.


Behavior, Animal/drug effects , Brain/enzymology , Cadmium/toxicity , Food Contamination/analysis , Solanum tuberosum/chemistry , Acetylcholinesterase/metabolism , Animals , Diet , Male , Maze Learning/drug effects , Random Allocation , Rats , Sodium-Potassium-Exchanging ATPase/genetics , Sodium-Potassium-Exchanging ATPase/metabolism
18.
Life Sci ; 90(9-10): 351-9, 2012 Feb 27.
Article En | MEDLINE | ID: mdl-22227472

AIMS: To investigate the 17-ß estradiol in the acetylcholinesterase activity and lipid peroxidation in the brain and blood of ovariectomized rats of different ages. MAIN METHODS: Animals were randomly assigned into three experimental groups of each age (n=6). Control groups consisted of adult (sham-A) and middle-aged (sham-MA) female rats, ovariectomized adult (OVX-A) and middle-aged (OVX-MA) rats without estrogen therapy reposition, and ovariectomized adult (OVX+E2-A) and middle-aged (OVX+E2-MA) rats treated with 17-ß estradiol for 30days. After this period, AChE activity and lipid peroxidation were measured in the brain and blood. KEY FINDINGS: The AChE activity increased (p<0.05) in striatum (ST) in OVX-A, OVX+E2-A and OVX-MA, and hippocampus (HP) in OVX-MA. The enzyme activity decreased (p<0.05) in ST of OVX+E2-MA, and cerebral cortex (CC) in OVX+E2-A, OVX-MA and OVX+E2-MA. Blood AChE activity increased (p<0.05) in OVX+E2-A and decreased (p<0.05) in OVX-MA. Lymphocyte AChE activity increased (p<0.05) in OVX-A and OVX+E2-A and decreased (p<0.05) in OVX-MA. Lipid peroxidation increased (p<0.05) in ST of OVX-A, CC of OVX-A and OVX-MA, HP of OVX-A, and cerebellum (CE) of OVX-A, OVX-MA, and OVX+E2-MA. Lipid peroxidation decreased (p<0.05) in ST, CC and CE of OVX+E2-A, and ST and HP of OVX+E2-MA. Similar values of lipid peroxidation to control groups were found in ST and HP of OVX-MA, HP of OVX+E2-A and CC of OVX+E2-MA. SIGNIFICANCE: 17-ß estradiol is able to modulate the AChE activity and non-neuronal cholinergic response as well as to reduce lipid peroxidation. Its response is dependent on the age and brain structure analyzed.


Acetylcholinesterase/metabolism , Brain/enzymology , Estradiol/administration & dosage , Estrogens/administration & dosage , Lipid Peroxidation/drug effects , Lymphocytes/enzymology , Acetylcholinesterase/blood , Age Factors , Animals , Estrogen Replacement Therapy , Female , Models, Animal , Organ Specificity , Ovariectomy , Oxidative Stress/drug effects , Rats , Rats, Wistar
...